María José Alonso

María José Alonso is a renowned biopharmaceutical scientist and professor of Pharmaceutics at the University of Santiago de Compostela. She is recognized for her pioneering work in the field of nanotechnology and drug delivery systems, particularly in the design and development of novel nanoparticles for targeted drug delivery.

Early Life and Education[edit | edit source]

María José Alonso was born in Spain. She pursued her undergraduate studies in Pharmacy at the University of Santiago de Compostela. After obtaining her degree, she continued her education in the same institution, earning a PhD in Pharmacy.

Career[edit | edit source]

Alonso's career has been marked by her significant contributions to the field of nanomedicine. She has been instrumental in the development of new nanocarrier systems for the delivery of drugs and vaccines. Her research has focused on overcoming the barriers that hinder the effective delivery of therapeutic agents, particularly in the treatment of cancer, HIV, and other serious diseases.

She has published over 250 scientific articles in prestigious international journals and has been granted several patents related to her work. Alonso is also a member of the editorial board of several scientific journals in the field of pharmaceutics and nanotechnology.

Awards and Recognition[edit | edit source]

Alonso's work has earned her numerous awards and recognition. She is a fellow of the Controlled Release Society (CRS) and was the first woman to receive the CRS Founders Award in 2016. She has also been awarded the Spanish Royal Academy of Pharmacy's Medal and the FEBS/Elsevier Award for her outstanding contributions to the field of biopharmaceuticals.